A clinical trial led by Rush University Medical Center and the MIND Institute at UC Davis have found that mavoglurant, an experimental drug known as mGluR5 negative modulator, can positively modify a key characteristic behavior in individuals with fragile X syndrome...
Fragile X Children
Category
Nemours Children Participates in Fragile X Children’s Trial
Commercial sponsor Neurotrope announced it will initiate a clinical trial in children with fragile X syndrome. The company, which will conduct the trial in collaboration with the The Nemours/Alfred I. duPont Hospital for Children, in Wilmington, Delaware, have not...